Stericycle, Inc. SRCL is slated to report second-quarter 2018 results on Aug 2 after the bell.
Decline in revenues from the majority of its services is likely to dent the company's top line in the to-be-reported quarter. The Zacks Consensus Estimate for second quarter revenues is pegged at $896 million, mirroring a year-over-year decline of 2.4%.
So far this year, shares of Stericycle have gained just 2.8%, underperforming the S&P 500's rally of 5.1%.
Here are the expectations in details.
The Zacks Consensus Estimate for Regulated Waste and Compliance Services revenues in the to-be-reported quarter is pegged at $486 million, reflecting a year-over-year decline of 5.1%. The expected decline is likely to be due to impacts of divestitures in Patient Transportation, and the SQ business. These revenues declined 2.7% in the first quarter.
Stericycle, Inc. Revenue (TTM)
Stericycle, Inc. Revenue (TTM) | Stericycle, Inc. Quote
The consensus mark for Communication and Related Services revenues is $92 million, indicating year-over-year decline of 10.7%. These revenues increased 1.7% in the first quarter. The same for Manufacturing and Industrial Services revenues stands at $89 million, indicating a 1.1% year-over-year decline. These revenues increased 2.6% in the first quarter.
The consensus estimate for Secure Information Destruction Services revenues stands at $229 million, indicating year-over-year growth of 8%. Sales teams are expected to perform well, driven by process improvement and automation implemented in the recent times. These revenues increased 7.7% in the first quarter.
Stericycle currently carries a Zacks Rank #3 (Hold). You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here .
Investors interested in the broader Business Services sector are keenly awaiting second-quarter earnings reports from key players like Avis Budget CAR , Genpact G and Delphi Technologies DLPH . While Avis Budget and Genpact will report their quarterly numbers on Aug 7, Delphi Technologies will release results on Aug 8.
Looking for Stocks with Skyrocketing Upside?
Zacks has just released a Special Report on the booming investment opportunities of legal marijuana.
Ignited by new referendums and legislation, this industry is expected to blast from an already robust $6.7 billion to $20.2 billion in 2021. Early investors stand to make a killing, but you have to be ready to act and know just where to look.
See the pot trades we're targeting>>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Avis Budget Group, Inc. (CAR): Free Stock Analysis Report Delphi Technologies PLC (DLPH): Free Stock Analysis Report Genpact Limited (G): Free Stock Analysis Report Stericycle, Inc. (SRCL): Free Stock Analysis Report To read this article on Zacks.com click here. Zacks Investment Research